20 related articles for article (PubMed ID: 38501412)
1. ICAM-1 may promote the loss of dopaminergic neurons by regulating inflammation in MPTP-induced Parkinson's disease mouse models.
Zhang F; Pan L; Lian C; Xu Z; Chen H; Lai W; Liang X; Liu Q; Wu H; Wang Y; Zhang P; Zhang G; Liu Z
Brain Res Bull; 2024 May; 214():110989. PubMed ID: 38825252
[TBL] [Abstract][Full Text] [Related]
2. Optimization of the Preparation Process of Glucuronomannan Oligosaccharides and Their Effects on the Gut Microbiota in MPTP-Induced PD Model Mice.
Wang B; Geng L; Wang J; Wei Y; Yan C; Wu N; Yue Y; Zhang Q
Mar Drugs; 2024 Apr; 22(5):. PubMed ID: 38786584
[TBL] [Abstract][Full Text] [Related]
3. The TLR4/NF-κB/NLRP3 and Nrf2/HO-1 pathways mediate the neuroprotective effects of alkaloids extracted from Uncaria rhynchophylla in Parkinson's disease.
Zhang C; Zhou J; Zhuo L; Zhang W; Lv L; Zhu L; Zhang J; Feng F; Liu W; Han L; Liao W
J Ethnopharmacol; 2024 May; ():118391. PubMed ID: 38797377
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol Inhibits VDAC1-Mediated Mitochondrial Dysfunction to Mitigate Pathological Progression in Parkinson's Disease Model.
Feng S; Gui J; Qin B; Ye J; Zhao Q; Guo A; Sang M; Sun X
Mol Neurobiol; 2024 May; ():. PubMed ID: 38819635
[TBL] [Abstract][Full Text] [Related]
5. Electroacupuncture blocked motor dysfunction and gut barrier damage by modulating intestinal NLRP3 inflammasome in MPTP-induced Parkinson's disease mice.
Guo L; Hu H; Jiang N; Yang H; Sun X; Xia H; Ma J; Liu H
Heliyon; 2024 May; 10(9):e30819. PubMed ID: 38774094
[TBL] [Abstract][Full Text] [Related]
6. Nigrostriatal Inflammation Is Associated with Nonmotor Symptoms in an Experimental Model of Prodromal Parkinson's Disease.
Oliveira BDS; Toscano ECB; Abreu LKS; Fernandes HB; Amorim RF; Ferreira RN; Machado CA; Carvalho BC; da Silva MCM; de Oliveira ACP; Rachid MA; Rocha NP; Teixeira AL; da Silva ER; de Miranda AS
Neuroscience; 2024 May; 549():65-75. PubMed ID: 38750924
[TBL] [Abstract][Full Text] [Related]
7. Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF-KB pathway.
Lv J; Zhu J; Wang P; Liu T; Yuan J; Yin H; Lan Y; Sun Q; Zhang Z; Ding G; Zhou C; Wang H; Wang Z; Wang Y
CNS Neurosci Ther; 2023 Apr; 29(4):1012-1023. PubMed ID: 36691817
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
Cui C; Hong H; Shi Y; Zhou Y; Qiao CM; Zhao WJ; Zhao LP; Wu J; Quan W; Niu GY; Wu YB; Li CS; Cheng L; Hong Y; Shen YQ
J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):72-89. PubMed ID: 35091889
[TBL] [Abstract][Full Text] [Related]
9. Wuzi Yanzong Pill relieves MPTP-induced motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation.
Pan T; Xiao Q; Fan HJ; Xu L; Qin SC; Yang LX; Jin XM; Xiao BG; Zhang B; Ma CG; Chai Z
Metab Brain Dis; 2023 Oct; 38(7):2211-2222. PubMed ID: 37470879
[TBL] [Abstract][Full Text] [Related]
10. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
11. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells.
Huang P; Zhang Z; Zhang P; Feng J; Xie J; Zheng Y; Liang X; Zhu B; Chen Z; Feng S; Wang L; Lu J; Liu Y; Zhang Y
Mol Neurobiol; 2024 May; 61(5):2590-2605. PubMed ID: 37917301
[TBL] [Abstract][Full Text] [Related]
12. [Resveratrol protects dopaminergic neurons in a mouse model of Parkinson's disease by regulating the gut-brain axis
Gui J; Sun X; Wen S; Liu X; Qin B; Sang M
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):270-279. PubMed ID: 38501412
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
